What's breaking now, across thousands of outlets.
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
MILAN — As more GLP-1-based drugs reach late-stage trials and post stronger and stronger weight loss effects, companies that want to enter the market are looking for differentiating factors.
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
→ Juan Andres will come out of retirement to rejoin Moderna as COO on Oct. 5, bringing his intimate knowledge of the company as its Merck-partnered cancer vaccine gathers momentum in the clinic.
As our lives become increasingly digital, vision care will need to evolve alongside them.
The American College of Chest Physicians (CHEST) has released a new clinical guideline for tobacco treatment in the inpatient setting.
Congo's Ebola outbreak has now recorded more than 4,000 deaths, authorities said, in what has become the fastest-growing Ebola outbreak in history.
